Download 1 Meeting: Cancer Alliance Clinical Leadership Group Date: 4 May

Meeting:
Cancer Alliance Clinical Leadership Group
Date:
4 May 2017
Time:
10.00am
Venue:
Evolve Business Centre
Present:
Name
In
attendance:
Apologies:
Rachel Bannister-Young, Lead Cancer Nurse, Sunderland
Paul Barrett, Skin Chair, CDDFT
Richard Bliss , Lead Clinician Newcastle
Tony Branson, (Chair) Clinical Lead, Cancer Alliance
Alison East, Macmillan Lead Cancer Nurse Newcastle
Simon Endersby , Head and Neck Chair, Nuth
Nicky Hand, South Tees representing Angela Wood
Jan Harley Lead Cancer Nurse N Tees & Hartlepool
Carolyn Harper, Cancer Manager Gateshead
Kath Jones, Alliance Delivery Lead, Cancer Alliance
Mark Katory Cancer Clinical Lead Gateshead
Jo MacIntosh, Macmillan Engagement and co-design manager
Adrienne Moffett, CA Delivery Manager
Sheila Pearson Cancer Clinical Lead, North Cumbria
Mel Robertson, Cancer Lead Clinician, Sunderland
Jonathan Slade, GP
Oliver Schulte , Cancer Lead Clinical, South Tyneside
Jonathan Slade Alliance Clinical GP Lead
Chris Walker, Radiology Chair
Mark Weatherhead, Lead Clinician, Northumbria
Linda Wintersgill, Information and Data Manager, CA
Caron Woodward, Lead Cancer Nurse, CDDFT
Pat Wright, GP Lead , North Durham CCG
Claire McNeill Quality Surveillance Co-ordinator , Cancer
Alliance
Alison Featherstone, Manager, Cancer Alliance
Jonathan Aning Urology Chair, Newcastle
Chris Tasker, Network GP Cancer Lead, Cancer Alliance
Robin Armstrong,
Gail Jones, Haematology Chair, Newcastle
John Painter, Upper GI Chair
Angela Wood, Cancer Lead Clinical , South Tees
Tony Sproston, Gynae Chair, Northumbria
Ralph Jackson, Radiology Chair, Newcastle
Ian Pedley, Newcastle
Clare Scarlett North Tyneside CCG
Henry Choi, GP, Sunderland
Bill Hall, GP, South Tyneside
Initials
RBY
PB
RB
TB
AE
SE
NH
JH
CH
KJ
MK
JM
AM
SP
MR
JS
OS
JS
CW
MW
LW
CW
PW
CM
AF
JA
CT
RA
GJ
JP
AW
TS
RJ
IP
CS
HC
BH
1
MINUTES
1.
INTRODUCTION
Lead
Enc
1.1 Welcome and Apologies
TB welcomed all to the meeting, apologies as listed above.
1.2 Declaration of Conflict of Interest
There were no declarations of conflict of interest.
1.3 Minutes from Previous meeting 07.3.17
Minutes agreed as a true and accurate record.
Enc 1
1.4 Matters Arising

Endocrine
MT asked about the specific pathway for endocrine cancer
pathways. Information requested but not yet received once
this has been received information will be forwarded to the
group.
2.
AGENDA ITEMS UPDATES
2.1 Cancer Alliance Update

Delivery Plans
Delivery plan reviewed
received

and no additional comments
Cancer Transformation Bids
TB updated on the cancer transformation bids. Still
awaiting official confirmation but understand we have been
granted the whole account of the bid which is approx.
£6million over two years. Localities have been asked to
consider how they will utilise the two new posts in their
region.

Launch Event- Next Steps
TB felt the Northern Cancer Alliance launch event went
well. AM advised it is hoped to have another event next
year to look at progress made with the workplan.
2.2 MDT Effectiveness
2
TB updated group on the work being undertaken on MDT
effectiveness. Gap analysis is being undertaken and due to
be completed by August 2017 with a meeting to review this
analysis at a MDT review meeting which is due to be held
Friday 15 September 2017.
All providers to share benchmarking information at the
September meeting.
Alliance will develop a benchmarking tool to assist process
and all to share good examples of proformas.
MR advised the group she had not seen core member
attendance in any of the current Quality Surveillance
measures and queried if these had been removed already.
2.3 Upper GI Cancers
AM updated on the joint work being undertaken with
specialised commissioning and the cancer alliance.
AM requested the group to endorse the tertiary referral
form which has been approved by Upper GI Expert
Advisory Group. AM will send out via email, if anyone has
any objection please email [email protected]
within two weeks or receiving email. If no objections
received by 23 May document will be considered
endorsed.
AM
MR asked if trusts could copy the form, with all relevant
information, onto their own Trust forms, and would this be
acceptable. This would assist the trust in having some
data self-populated and reduce time taken to complete. TB
confirmed if the data was in the same place this would be
acceptable and would be more efficient for the trusts.
2.4 Regional Breast Services
TB updated group on work being undertaken to review
regional breast services. KJ advised an updated report
would be sent via email for information.
2.5 Diagnostics
Update report was circulated with the minutes.
Unfortunately neither Katie Elliot nor Chris Tasker could
3
attend this meeting.
2.6 No smoking Event 26 April - Updates
TB advised there was a presentation by Angus Bell at the
Northern Cancer Alliance Launch event showing progress
made in reducing smoking in the Mental Health Trust
Regional Task force – Smoke free NHS held its first
meeting on the 26 April and looking at a number of
different pieces of work and how the cancer alliance could
contribute to this.
Next meeting is due to be held on the 12 July 2017.
RC discussed the variation between trusts and obstacles
such as who takes responsibility to police this. TB also
discussed the impact of staff who smoke.
2.7 2ww referral forms
Currently requesting feedback, via online survey, from both
Primary and Secondary care to ensure the forms are
appropriate and to make any appropriate changes if
needed.
Link provided to access the survey.
All feedback needs to be completed by the end of May.
SE queried head and neck 2ww referral form and the new
National advice for a dental referral and asked if this was
impacting on 2ww.
KJ advised the Head and Neck Expert Advisory Group
didn’t agree with this requirement and it’s not included
within the alliance 2ww referral form. JS advised numbers
were small and he agreed patients would not put any
importance on the GPs advising them to refer to a dentist.
3.
AGENDA ITEMS FOR DISCUSSION
3.1
Lung Pathways
The Alliance is committed to reducing variation in services
and improving outcomes regionally. To start this work an
4
event has been arranged due to be held on the 23 June
at the Radisson Blu in Durham by invitation only. Trusts
have been asked to provide 10 appropriate delegates for
different specialities to look how to introduce this into
practise and share best practise.
KJ will be inviting primary care to the meeting via the
cancer in the community distribution lists.
.
3.2
KJ
Performance Report
LW advised data is sparse, now have 8 months of data
and generally if patients are referred pathway is longer.
Median transfer date across all sites is 33 days but there
is variation between tumour sites. Lung median transfer
date is above the nationally recommended 38 days.
Work will continue to monitor allocations and transfer
points at rumour and trust level.
Work with EAGs to incorporate realistic transfer points
into pathways and review data with the group.
LW advised she is unsure when the new process will be
introduced.
Detailed report will be circulated via email. If anyone has
comments of feedback on the report to email
[email protected]
4.
STANDING ITEMS
4.1 Any other Business
 Sentinel node biopsies.
SE discussed NICE recommendations regarding Sentinel
node biopsies. Discussed the difficulties to implement in
other areas. PB advised if depends on the process chosen.
This will impact on outcome of test for the patients. NICE
recommendations state Sentinel node biopsies must be
offered to patients.
 Head and Neck - National audit
No reported data received. LW to investigate and update
the group via email.
LW
4.2 Next meeting
Friday 29 September 2017, 2.00-4.00 Evolve Business Centre
Tuesday 14 November 2017 10.00-12.00 (telecom)
5. MEETING CLOSE
Contact
[email protected]
tel 01138252976
5